Svetlana Mojsov

6.0k total citations · 3 hit papers
44 papers, 4.8k citations indexed

About

Svetlana Mojsov is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Svetlana Mojsov has authored 44 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in Svetlana Mojsov's work include Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (19 papers) and Neuropeptides and Animal Physiology (14 papers). Svetlana Mojsov is often cited by papers focused on Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (19 papers) and Neuropeptides and Animal Physiology (14 papers). Svetlana Mojsov collaborates with scholars based in United States, Canada and Hong Kong. Svetlana Mojsov's co-authors include Joel F. Habener, Gordon C. Weir, Daniel J. Drucker, Yang Wei, Jan Philippé, G. Heinrich, Ira B. Wilson, Mariella Ravazzola, Lelio Orci and Gustaf N. Hendrick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Svetlana Mojsov

44 papers receiving 4.6k citations

Hit Papers

Glucagon-like peptide I s... 1986 2026 1999 2012 1987 1987 1986 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svetlana Mojsov United States 28 2.7k 2.2k 1.6k 1.1k 633 44 4.8k
Marvin Bayne United States 39 1.2k 0.4× 766 0.4× 3.1k 2.0× 1.4k 1.2× 634 1.0× 66 5.2k
Jean Morisset Canada 29 624 0.2× 1.1k 0.5× 1.2k 0.7× 534 0.5× 289 0.5× 171 3.2k
Robert L. Sorenson United States 37 1.8k 0.7× 2.9k 1.3× 1.5k 0.9× 267 0.2× 129 0.2× 96 4.7k
Xiaorong Zhu United States 28 535 0.2× 739 0.3× 1.5k 0.9× 473 0.4× 273 0.4× 60 3.3k
Francis C. Lynn Canada 30 1.3k 0.5× 1.9k 0.9× 1.9k 1.2× 634 0.6× 87 0.1× 75 3.8k
Lauge Schäffer Denmark 24 1.4k 0.5× 827 0.4× 1.8k 1.1× 434 0.4× 83 0.1× 29 3.1k
Françoise Cluzeaud France 38 530 0.2× 583 0.3× 3.0k 1.9× 732 0.7× 271 0.4× 71 4.5k
Pomila Singh United States 37 564 0.2× 1.0k 0.5× 1.6k 1.0× 637 0.6× 210 0.3× 125 3.7k
Esper Boel Denmark 33 916 0.3× 1.2k 0.5× 1.7k 1.1× 389 0.4× 315 0.5× 54 3.8k
Burton M. Wice United States 23 553 0.2× 721 0.3× 1.8k 1.1× 194 0.2× 191 0.3× 42 3.2k

Countries citing papers authored by Svetlana Mojsov

Since Specialization
Citations

This map shows the geographic impact of Svetlana Mojsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svetlana Mojsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svetlana Mojsov more than expected).

Fields of papers citing papers by Svetlana Mojsov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svetlana Mojsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svetlana Mojsov. The network helps show where Svetlana Mojsov may publish in the future.

Co-authorship network of co-authors of Svetlana Mojsov

This figure shows the co-authorship network connecting the top 25 collaborators of Svetlana Mojsov. A scholar is included among the top collaborators of Svetlana Mojsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svetlana Mojsov. Svetlana Mojsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mojsov, Svetlana. (2024). Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity. JAMA. 332(20). 1695–1695. 2 indexed citations
2.
Fujii, Shin‐ichiro, Toyotaka Kawamata, Kanako Shimizu, et al.. (2022). Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML. Molecular Therapy — Oncolytics. 27. 315–332. 13 indexed citations
3.
Irwin, David M. & Svetlana Mojsov. (2018). Diversification of the functions of proglucagon and glucagon receptor genes in fish. General and Comparative Endocrinology. 261. 148–165. 22 indexed citations
5.
Bozzacco, Leonia, Haiqiang Yu, Jörn Dengjel, et al.. (2012). Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the HIV Gag p24 Protein. PLoS ONE. 7(7). e41897–e41897. 7 indexed citations
6.
Yang, Wei & Svetlana Mojsov. (2006). Multiple Human Receptors for Pituitary Adenylyl Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Are Expressed in a Tissue-Specific Mannera. Annals of the New York Academy of Sciences. 805(1). 624–627. 17 indexed citations
7.
Beaulieu, Sylvie, Davide F. Robbiani, Elaine G. Rodrigues, et al.. (2002). Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells. The Journal of Immunology. 169(6). 2925–2936. 56 indexed citations
9.
Ignatius, Ralf, Wei Yang, Sylvie Beaulieu, et al.. (2000). Short Communication: The Immunodeficiency Virus Coreceptor, Bonzo/STRL33/TYMSTR, Is Expressed by Macaque and Human Skin- and Blood-Derived Dendritic Cells. AIDS Research and Human Retroviruses. 16(11). 1055–1059. 13 indexed citations
11.
Yang, Wei, et al.. (1998). Cloning and Functional Characterization of PACAP‐Specific Receptors in Zebrafish. Annals of the New York Academy of Sciences. 865(1). 45–48. 17 indexed citations
12.
Wei, Yau‐Huei & Svetlana Mojsov. (1996). Distribution of GLP‐1 and PACAP receptors in human tissues. Acta Physiologica Scandinavica. 157(3). 355–357. 62 indexed citations
14.
Hendrick, Gustaf N., Asllan Gjinovci, Svetlana Mojsov, et al.. (1993). Glucagon-like peptide-I-(7–37) suppresses hyperglycemia in rats. Metabolism. 42(1). 1–6. 27 indexed citations
15.
Mojsov, Svetlana. (1992). Structural requirements for biological activity of glucagon‐like peptide‐I. International journal of peptide & protein research. 40(3-4). 333–343. 24 indexed citations
16.
Blackmore, P F, Svetlana Mojsov, John H. Exton, & Joel F. Habener. (1991). Absence of insulinotropic glucagon‐like peptide‐I(7–37) receptors on isolated rat liver hepatocytes. FEBS Letters. 283(1). 7–10. 39 indexed citations
17.
Gefel, Dov, Gustaf N. Hendrick, Svetlana Mojsov, Joel F. Habener, & Gordon C. Weir. (1990). Glucagon-Like Peptide-I Analogs: Effects on Insulin Secretion and Adenosine 3′,5′-Monophosphate Formation*. Endocrinology. 126(4). 2164–2168. 87 indexed citations
18.
Weir, Gordon C., Svetlana Mojsov, Gustaf N. Hendrick, & Joel F. Habener. (1989). Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas. Diabetes. 38(3). 338–342. 216 indexed citations
19.
Drucker, Daniel J., Jan Philippé, & Svetlana Mojsov. (1988). Proglucagon Gene Expression and Posttranslational Processing in a Hamster Islet Cell Line*. Endocrinology. 123(4). 1861–1867. 46 indexed citations
20.
Drucker, Daniel J., Svetlana Mojsov, & Joel F. Habener. (1986). Cell-specific post-translational processing of preproglucagon expressed from a metallothionein-glucagon fusion gene.. Journal of Biological Chemistry. 261(21). 9637–9643. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026